Endpoints has more than 163,000 subscribers and distributes content via its daily news reports and website, and at in-person and online events.
This acquisition marks a significant milestone in the FT’s expansion in the U.S., where Endpoints is based, and deepens the FT’s coverage of the dynamic biopharma sector.
“We’re thrilled to invest in Endpoints, a fast-growing business with a robust reputation for delivering quality news to audiences across the biopharma ecosystem,” said FT Group CEO John Ridding in a statement. “There is strong alignment between Endpoints and the FT in terms of mission, business model and focus on reader revenues. This acquisition also supports our ambitions to reach new audiences in innovative sectors and grow our footprint in the U.S.”
Endpoints was founded seven years ago.
Modern Retail, Digiday Media’s retail-focused digital publication, is looking for an enterprising journalist to chronicle…
Reuters seeks a driven reporter to join its Canada team to cover agriculture. It is…
Lisa Wolfson, who has been an editor at Bloomberg News for the past 27 years,…
Joe Mysak, who has been covering municipal bonds for 43 years, is retiring at the…
Gordon Gottsegen joined MarketWatch.com as a retail investing reporter, focusing consumers who trade on popular…
Bloomberg News has hired Laura Noonan in London as a senior reporter covering a broad financials beat.…